Skip to main content
Premium Trial:

Request an Annual Quote

NoAb BioDiscoveries

Premium
NoAb BioDiscoveries this week launched DTEx, a microarray-based technology that profiles the effects of drugs on the gene expression of key proteins involved in drug metabolism.
 
DTEx analyzes the effects of drugs on the induction or suppression of transporter genes that play a critical role in determining the pharmacodynamic and pharmacokinetic properties of administered drugs. “This information will help scientists understand potential drug-drug interactions and to select candidates for clinical development with greater efficacy and fewer side effects,” NoAb said. The company has filed patent applications for the DTEx technology.

Filed under

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.